GELS

GELTEQ LIMITED

GELS·Q3978B109·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic

GELS (GELTEQ LIMITED) is held by 4 institutional investors as of Q2 2026. Largest holders: JANE STREET GROUP, LLC ($20,208), MORGAN STANLEY ($10,050), CITADEL ADVISORS LLC ($7,676). Net institutional sentiment: Mixed.

4
Holders
$38,017
Total Value
33% (6)
Consensus
2 buying - 4 selling
13F: Insider & Congress: Updated regularly
GELS

Smart Money Verdict

View all
Loading verdict
Held by 4 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for GELS.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
30,161$20,2080.0%-13.46%
29
New
15,000$10,0500.0%-13.46%
26
Decreased
11,457(-17.2%)$7,6760.0%-22.69%
0
Decreased
125(-93.2%)$830.0%-22.69%
0
Exited
0(-100.0%)$6,6440.0%-17.28%
0
Exited
0(-100.0%)$11,0180.0%-10.67%
0
GELSGELSGELTEQ LIMITED

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used